
### [NCIT:C80328](http://purl.obolibrary.org/obo/NCIT_C80328)
**Label:** B Lymphoblastic Leukemia/Lymphoma with Recurrent Genetic Abnormalities

**Subclasses:** [NCIT:C80338](http://purl.obolibrary.org/obo/NCIT_C80338) (B Lymphoblastic Leukemia/Lymphoma with Hypodiploidy), [NCIT:C80347](http://purl.obolibrary.org/obo/NCIT_C80347) (B Acute Lymphoblastic Leukemia with t(1;19)(q23;p13.3); E2A-PBX1 (TCF3-PBX1)), [NCIT:C80346](http://purl.obolibrary.org/obo/NCIT_C80346) (B Acute Lymphoblastic Leukemia with t(5;14)(q31.1;q32.3); IL3-IGH), [NCIT:C80335](http://purl.obolibrary.org/obo/NCIT_C80335) (B Lymphoblastic Leukemia/Lymphoma with Hyperdiploidy), [NCIT:C80345](http://purl.obolibrary.org/obo/NCIT_C80345) (Hypodiploid B Acute Lymphoblastic Leukemia), [NCIT:C80334](http://purl.obolibrary.org/obo/NCIT_C80334) (B Lymphoblastic Leukemia/Lymphoma with t(12;21)(p13.2;q22.1); ETV6-RUNX1), [NCIT:C80344](http://purl.obolibrary.org/obo/NCIT_C80344) (Hyperdiploid B Acute Lymphoblastic Leukemia), [NCIT:C80343](http://purl.obolibrary.org/obo/NCIT_C80343) (B Acute Lymphoblastic Leukemia with t(12;21)(p13.2;q22.1); ETV6-RUNX1), [NCIT:C80332](http://purl.obolibrary.org/obo/NCIT_C80332) (B Lymphoblastic Leukemia/Lymphoma with t(v;11q23.3); KMT2A Rearranged), [NCIT:C80331](http://purl.obolibrary.org/obo/NCIT_C80331) (B Lymphoblastic Leukemia/Lymphoma with t(9;22)(q34.1;q11.2); BCR-ABL1), [NCIT:C80342](http://purl.obolibrary.org/obo/NCIT_C80342) (B Acute Lymphoblastic Leukemia with t(v;11q23.3); KMT2A Rearranged), [NCIT:C68659](http://purl.obolibrary.org/obo/NCIT_C68659) (Childhood B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1), [NCIT:C80341](http://purl.obolibrary.org/obo/NCIT_C80341) (B Lymphoblastic Leukemia/Lymphoma with t(1;19)(q23;p13.3); E2A-PBX1 (TCF3-PBX1)), [NCIT:C80340](http://purl.obolibrary.org/obo/NCIT_C80340) (B Lymphoblastic Leukemia/Lymphoma with t(5;14)(q31.1;q32.3); IL3-IGH), [NCIT:C114819](http://purl.obolibrary.org/obo/NCIT_C114819) (Adult B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1), [NCIT:C36312](http://purl.obolibrary.org/obo/NCIT_C36312) (B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1), 

**Class expressions from DL-Learner:**

- Thing 53.84%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) 37.53%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39818](http://purl.obolibrary.org/obo/NCIT_C39818) (Infiltrating Bladder Urothelial Carcinoma with Trophoblastic Differentiation))) 37.53%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39817](http://purl.obolibrary.org/obo/NCIT_C39817) (Infiltrating Bladder Urothelial Carcinoma with Glandular Differentiation))) 37.53%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39816](http://purl.obolibrary.org/obo/NCIT_C39816) (Infiltrating Bladder Urothelial Carcinoma with Squamous Differentiation))) 37.53%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39815](http://purl.obolibrary.org/obo/NCIT_C39815) (Cellular Congenital Mesoblastic Nephroma))) 37.53%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39814](http://purl.obolibrary.org/obo/NCIT_C39814) (Classic Congenital Mesoblastic Nephroma))) 37.53%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39813](http://purl.obolibrary.org/obo/NCIT_C39813) (SMARCB1 Gene Inactivation))) 37.53%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39812](http://purl.obolibrary.org/obo/NCIT_C39812) (Metanephric Adenofibroma))) 37.53%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39811](http://purl.obolibrary.org/obo/NCIT_C39811) (t(5;11)(q35;q13)))) 37.53%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39810](http://purl.obolibrary.org/obo/NCIT_C39810) (Type 2 Renal Papillary Adenoma))) 37.53%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39809](http://purl.obolibrary.org/obo/NCIT_C39809) (Type 1 Renal Papillary Adenoma))) 37.53%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39808](http://purl.obolibrary.org/obo/NCIT_C39808) (Asymptomatic Mass))) 37.53%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39807](http://purl.obolibrary.org/obo/NCIT_C39807) (Mucinous Tubular and Spindle Cell Carcinoma of the Kidney))) 37.53%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39806](http://purl.obolibrary.org/obo/NCIT_C39806) (NONO-TFE3 Fusion Protein Expression))) 37.53%


